|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2005-11-8
|
|
pubmed:abstractText |
Mineralocorticoid receptor antagonism reduces mortality associated with heart failure by mechanisms that remain unclear. The effects of the mineralocorticoid receptor antagonist spironolactone on left ventricular (LV) function and chamber stiffness associated with myocardial fibrosis were investigated in mildly symptomatic patients with idiopathic dilated cardiomyopathy (DCM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AmanoTetsuyaT,
pubmed-author:AsanoHiroyukiH,
pubmed-author:IchiharaSahokoS,
pubmed-author:IinoShigeoS,
pubmed-author:IsobeSatoshiS,
pubmed-author:IzawaHideoH,
pubmed-author:KatoTomokoT,
pubmed-author:MuraseYosukeY,
pubmed-author:MuroharaToyoakiT,
pubmed-author:NagataKohzoK,
pubmed-author:NodaAkikoA,
pubmed-author:ObataKojiK,
pubmed-author:OhshimaSatoruS,
pubmed-author:OkumuraKenjiK,
pubmed-author:YokotaMitsuhiroM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2940-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16275882-Adult,
pubmed-meshheading:16275882-Aged,
pubmed-meshheading:16275882-Aldosterone Antagonists,
pubmed-meshheading:16275882-Biopsy,
pubmed-meshheading:16275882-Cardiomyopathy, Dilated,
pubmed-meshheading:16275882-Female,
pubmed-meshheading:16275882-Fibrosis,
pubmed-meshheading:16275882-Heart Failure,
pubmed-meshheading:16275882-Humans,
pubmed-meshheading:16275882-Male,
pubmed-meshheading:16275882-Middle Aged,
pubmed-meshheading:16275882-Pilot Projects,
pubmed-meshheading:16275882-Receptors, Mineralocorticoid,
pubmed-meshheading:16275882-Spironolactone,
pubmed-meshheading:16275882-Ventricular Dysfunction, Left
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
|
|
pubmed:affiliation |
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. izawa@med.nagoya-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
